The functional type of assay involves inhibiting the growth of human MFH-ino cells in an in vitro cell viability assay using SANGER technology. The non-molecular target assigned to the assay relates to Homo sapiens as the assay organism while the MFH-ino cell type is used in the assay. Does this molecule show effectiveness in this assay?